$AVNT · Avient Corporation Congress Trades

Hon. Gilbert Cisneros executed a highly active trading program in March 2026 involving over 100 transactions across the 150 Main Street Trust. Major transactions included a $250,001-$500,000 purchase of California Health Facilities Financing Authority bonds, sales of Archer-Daniels-Midland ($50,001-$100,000), DigitalBridge Group ($50,001-$100,000), and John Swett GO Bonds ($100,001-$250,000), alongside numerous purchases and partial sales of individual stocks ranging from $1,001-$50,000 each, with notable positions in technology, healthcare, and financial services sectors.

Rep. Gilbert Cisneros (CA-31) conducted extensive portfolio rebalancing through the 150 Main Street Trust during August-September 2025, executing approximately 80 transactions across diverse sectors. The activity included numerous purchases and sales of individual stocks ranging from $1,001-$15,000 each, with two notable larger positions: LandBridge Company LLC ($50,001-$100,000) and Strategy Inc preferred stock ($15,001-$50,000), plus a $15,001-$50,000 sale of UnitedHealth Group shares and a $15,001-$50,000 sale of Ralliant Corporation stock.

Rep. Lisa McClain (MI-09) conducted extensive trading activity across her Charles Schwab brokerage and 401(k) accounts from March 2024 through August 2025, trading dozens of stocks including major tech companies (AAPL, GOOGL, GOOG, AMZN, ADBE, AMD), healthcare (ABT, ABBV, AMGN, AZN), and industrials (ASML, ACN, AMAT). Most individual transactions ranged from $1,001-$15,000, with one AMD sale reaching $15,001-$50,000. The filing shows frequent buy-and-sell activity in the same securities within weeks, suggesting active portfolio management.

Hon. Josh Gottheimer conducted 34 transactions in June 2022, predominantly selling partial positions across a diversified portfolio including major stocks like Starbucks (SBUX, $15,001-$50,000), Microsoft (MSFT), Oracle (ORCL), Apple (AAPL), and numerous others, with a smaller number of purchases in stocks like UnitedHealth Group (UNH), Arcutis Biotherapeutics (ARQT), and Kering (PPRUY). All transactions were executed through a Morgan Stanley Select UMA Account.